People · Operator
Named in public records as an officer, director or promoter · active 2009–2026 · Pharmaceuticals, Other Technology, Software / Tech, Biotechnology, Agriculture
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Jaguar Health, Inc. | — | Pharmaceuticals | Series C | $151.1M | $58.9M | 2014 |
| Jaguar Health, Inc. | Executive Officer | Pharmaceuticals | Series C | $42.8M | $178.4M | 2026 |
| Innotas | — | Other Technology | Series A | $17.7M | $90.2M | 2010 |
| NeuroClear Technologies, Inc. | — | Software / Tech | Series A | $14.9M | $298.2M | 2020 |
| Napo Pharmaceuticals Inc | — | Biotechnology | Seed | $10.1M | $6.1M | 2009 |
| Farmers Co-operative Mill & Elevator Association | — | Agriculture | Pre-Seed | $1.0M | $13.3M | 2017 |
Steven King at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven King on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.